|
Q2 2026
|
37 |
1,639,957 |
CGEM, Aktis Oncology, Inc., LQDA, RVMD
|
13F-HR
|
8/14/2026 |
000119312526352199 |
|
Q1 2026
|
41 |
1,294,902 |
DBVT, CGEM, Aktis Oncology, Inc., LQDA
|
13F-HR
|
5/15/2026 |
000119312526226995 |
|
Q4 2025
|
38 |
873,953 |
CGEM, MDGL, LQDA, TRVI
|
13F-HR
|
2/17/2026 |
000119312526054813 |
|
Q3 2025
|
40 |
610,879 |
MDGL, CGEM, RNA, TRVI
|
13F-HR
|
11/14/2025 |
000119312525283112 |
|
Q2 2025
|
44 |
577,150 |
CGEM, MDGL, ZLAB, GH
|
13F-HR
|
8/14/2025 |
000095012325008431 |
|
Q1 2025
|
43 |
581,677 |
CGEM, MDGL, ZLAB, EWTX
|
13F-HR
|
5/15/2025 |
000095012325005756 |
|
Q4 2024
|
47 |
704,362 |
CGEM, CRNX, EWTX, INSM
|
13F-HR
|
2/14/2025 |
000095012325002794 |
|
Q3 2024
|
43 |
666,570 |
CGEM, INSM, OLMA, RNA
|
13F-HR
|
11/12/2024 |
000095012324011026 |
|
Q2 2024
|
44 |
643,506 |
CGEM, INSM, OLMA, ITOS
|
13F-HR
|
8/14/2024 |
000095012324008626 |
|
Q1 2024
|
38 |
621,981 |
CGEM, GERN, IOVA, ZNTL
|
13F-HR
|
5/15/2024 |
000095012324005704 |
|
Q4 2023
|
32 |
427,428 |
CGEM, IOVA, OLMA, GERN
|
13F-HR
|
2/13/2024 |
000095012324001863 |
|
Q3 2023
|
32 |
374,602 |
CGEM, OLMA, GERN, RPTX
|
13F-HR
|
11/14/2023 |
000095012323010967 |
|
Q2 2023
|
34 |
496,602 |
CGEM, ISEE, KDNY, GERN
|
13F-HR
|
8/14/2023 |
000095012323007806 |
|
Q1 2023
|
31 |
384,916 |
CGEM, PRVB, ISEE, ITOS
|
13F-HR
|
5/12/2023 |
000095012323004668 |
|
Q4 2022
|
33 |
385,456 |
CGEM, ITOS, INBX, RPTX
|
13F-HR
|
2/14/2023 |
000095012323002440 |
|
Q3 2022
|
38 |
422,223 |
CGEM, ITOS, INBX, VERV
|
13F-HR
|
11/14/2022 |
000095012322011895 |
|
Q2 2022
|
37 |
359,998 |
CGEM, ITOS, RPTX, MRUS
|
13F-HR
|
8/11/2022 |
000095012322008475 |
|
Q1 2022
|
37 |
372,610 |
CGEM, ITOS, MRUS, RPTX
|
13F-HR
|
5/13/2022 |
000095012322005661 |
|
Q4 2021
|
33 |
548,527 |
CGEM, ITOS, RPTX, MEIP
|
13F-HR
|
2/11/2022 |
000095012322002162 |
|
Q3 2021
|
33 |
644,676 |
CGEM, ITOS, RPTX, HOWL
|
13F-HR
|
11/15/2021 |
000095012321015022 |
|
Q2 2021
|
14 |
608,714 |
CGEM, ITOS, TCRR, RPTX
|
13F-HR
|
8/13/2021 |
000095012321010730 |
|
Q1 2021
|
13 |
795,909 |
CGEM, HARP, ITOS, TCRR
|
13F-HR
|
5/13/2021 |
000095012321006277 |
|
Q4 2020
|
13 |
569,376 |
TCRR, RPTX, ITOS, ONCR
|
13F-HR/A
|
2/24/2021 |
000095012321003117 |
|
Q4 2020
|
16 |
588,506 |
TCRR, RPTX, ITOS, ONCR
|
13F-HR
|
2/16/2021 |
000095012321002268 |
|
Q3 2020
|
12 |
415,058 |
RPTX, TCRR, HARP, ITOS
|
RESTATEMENT
|
11/19/2020 |
000095012320012277 |
|
Q2 2020
|
11 |
376,116 |
RPTX, HARP, TCRR, MEI Pharma, Inc.
|
13F-HR
|
8/12/2020 |
000095012320008310 |
|
Q1 2020
|
10 |
163,704 |
HARP, EPZM, TCRR, GTHX
|
13F-HR
|
5/13/2020 |
000095012320004648 |
|
Q4 2019
|
12 |
282,172 |
HARP, EPZM, TCRR, GTHX
|
13F-HR
|
2/14/2020 |
000095012320002404 |